×
For best experience we recommend to activate Javascript in your browser.
CEBPB antibody (AA 199-345)
This Rabbit Polyclonal antibody specifically detects CEBPB in WB, ELISA and IHC. It exhibits reactivity toward Human.
Quick Overview for CEBPB antibody (AA 199-345) (ABIN7568504)
Target
See all CEBPB Antibodies
CEBPB
(CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
Reactivity
All reactivities for CEBPB antibodies
Human
Host
All hosts for CEBPB antibodies
Rabbit
Clonality
All clonalities for CEBPB antibodies
Polyclonal
Conjugate
All conjugates for CEBPB antibodies
This CEBPB antibody is un-conjugated
Application
All applications for CEBPB antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-CEBPB Antibody
(hide)
Binding Specificity
All epitopes for CEBPB antibodies
AA 199-345
Purpose
Anti-CEBPB Polyclonal antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human CEBPB (Met199-Cys345).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for CEBPB
(hide)
Target
CEBPB
(CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
Alternative Name
CEBPB
Background
Liver activator protein,Transcription factor 5,LIP,LAP,Liver-enriched inhibitory protein,TCF5,Nuclear factor NF-IL6,C/EBP beta,TCF-5,CCAAT/enhancer-binding protein beta,CEBPB,
UniProt
P17676
Pathways
Interferon-gamma Pathway , Autophagy , Brown Fat Cell Differentiation
Recently viewed
(hide)
Chat with us , powered by LiveChat